CesEffect of folic acid on hot flashesTable 1. Comparison with the demographic characteristics of your two study groups Variables Age (year) Gravidity Parity RANKL/RANK web Duration of menopause (months) Systolic blood pressure Diastolic blood pressure BMI Menopause Natural Induced Main Education level Secondary Collage University Occupation Housewife Employee Retired Enough revenue Yes No Somewhat Sports Never Sometimes Usually Generally Marital status Single Married Divorced WidowFolic acid Mean (SD) 52.94 (3.37) 4.88 (two.33) 4.11 (1.92) 38.31 (27.01) 110.57 (10.83) 69.71 (9.28) 27.40 (four.74) N ( ) 27 (77) 8 (23) 20 (57) 1 (three) three (eight) 11 (32) 23 (65) ten (29) two (six) 18 (50) three (9) 14 (41) 19 (53) ten (29) 4 (12) two (6) 1 (three) 29 (83) 0 five (14)Placebo Imply (SD) 53.05 (three.40) 4.82 (two.09) 4.05 (1.74) 38.48 (25.53) 106.28 (10.59) 66 (10.05) 26.54 (four.22) N ( ) 29 (83) 6 (17) 22 (62) 2 (six) 1 (3) 10 (29) 25 (72) 7 (20) three (eight) 16 (44) 7 (21) 12 (35) 17 (47) 9 (26) five (15) 4 (12) two (6) 27 (77) 0 six (17)Statistical index t=-0.14, P=0.88,df= 68 t=0.108, P=0.91, df=68 t=0.130, P=0.89, df=68 t=0.184, P=0.85, df=68 t=1.67, P=0.09, df=68 t=1.61, P=0.11, df=68 t=0.805, P=0.42, df=68 2=0.357 P=0.55, df=1 Z=-0.459 P=0.2=0.813 P=0.66, df=2 Z=-0.052 P=0.Z=-0.717 P=0.2=0.496 P=0.78, df=For the thought of variables U-Mann Whitney test was usedseverity just Opioid Receptor list before and just after therapy there was a considerable difference (p 0.05). There was no important distinction involving means of hot flash severity of the two groups within the initially week right after therapy; but, this difference was considerable inside the second, third, and fourth weeks after therapy (Table 2). There was no considerable distinction amongst the two groups prior to therapy with regards to the frequency of hot flashes (p = 0.47). There was a substantial distinction amongst the mean hot flash frequency of the groups before and following treatment (p 0.05). The mean hot flash frequency of your two groups had no important distinction in theCopyright 2013 by Tabriz University of Healthcare Sciencesfirst and second weeks immediately after remedy. However, there was a significant difference in the third and fourth weeks soon after remedy (Table three). The results also indicated that there was no significant difference among the two groups regarding the duration of hot flash before the therapy (p = 0.46). Within-group comparison showed a considerable difference concerning mean hot flash duration ahead of and following the remedy (p 0.05). There was no considerable difference involving the groups throughout the initial, second, and third weeks after therapy based on the mean hot flash duration. However, within the fourth week afterJournal of Caring Sciences, Jun 2013; 2 (two), 131-140|Bani et al.treatment there was a considerable differencebetween the two groups (Table four).Table two. Imply hot flush severity based on the adhere to up by time divisions inside the therapy groups Folic acid Imply (SD) 2.23 (0.677) 2.16 (0.789) 1.86 (0.584) 1.62 (0.621) 1.42 (0.654) F = 26.13 df = two.28 P 0.001 Placebo Imply (SD) 2.15 (0.673) two.14 (0.619) 1.96 (0.624) 1.95 (0.586) 1.99 (0.609) F = eight.83 df = 1.93 P 0.001 Statistical indicators(between-group) P = 0.59, df = 68, t = 0.531 P = 0.60, df = 1, F = 0.270 P = 0.03, df = 1, F = four.44 P = 0.00, df = 1, F = 16.09 P = 0.00, df = 1, F = 30.Just before therapy Very first week Second week Third week Fourth week ANOVA with repeatedmeasure(within-group)ANCOVATable three. Imply hot flash frequency depending on the follow up by time divisions in the treatment groups Folic acid Placebo Stat.